BLLN Earnings

BLLN reported its earnings on 2026-03-04, showcasing a revenue of 96.05M against an estimate of 85.85M, resulting in a 11.88% surprise. The EPS was 0.11, surpassing the expected 0.07 by 57.14%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following BLLN's earnings announcement on 2026-03-04, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, BLLN's stock price tends to shift by an average of 10.18% in the 10 days leading up to earnings and -10.25% in the 10 days following, providing insight into potential market.

For , analysts estimate BLLN's annual revenue to reach , while the EPS is projected at . These estimates reflect recent revisions, with revenue estimates revised upward by 2.33% and EPS estimates revised upward by 7.75% over the past three months, indicating analyst expectation in the company's performance.

The correlation between BLLN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised upward by 2.33%, while EPS estimates moved revised upward by 7.75%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, BLLN's stock price typically moves by 10.18% in the 10 days before its earnings and -10.25% in the 10 days after. For the upcoming earnings, analysts expect an EPS of and revenue of .

The earnings call highlights strong financial performance with significant revenue growth, improved gross margins, and a shift from net loss to net income. The Q&A section addresses strategic investments and a conservative guidance approach. Although management avoided specific 2026 guidance, the overall outlook is optimistic with robust revenue growth and strategic expansion plans in prenatal and oncology sectors. These factors suggest a positive stock price movement over the next two weeks.